Abstract

Objective: To evaluate the prevalence and patterns of complementary and alternative medicine (CAM) use among patients with inflammatory eye disease. Methods: This cross-sectional study was conducted over three months through direct interviews with 150 consecutive patients at a tertiary care clinic specializing in inflammatory eye diseases. Sociodemographic data and clinical characteristics were extracted from clinical records for analysis. Descriptive and comparative analyses were performed using IBM SPSS Statistics software. Results: In this cohort, 110 of the 150 patients (73.3%) reported employing complementary and alternative medicine (CAM) strategies to mitigate their ocular conditions. The CAM interventions included vitamin supplementation (n=53, 35%), herbal remedies (n=41, 27%), acupuncture (n=23, 15%), and leech therapy (n=11, 7%)—notably, a significant portion—roughly one in three patients—engaged in multiple CAM therapies. Statistical analysis revealed a robust association between CAM applications and several demographic and clinical variables. Females were more likely to use CAM (p=0.04), as were individuals with higher occupational standing (p=0.03) and income levels (p=0.03). Furthermore, patients diagnosed with uveitis exhibited a higher propensity for CAM usage than those with other inflammatory eye diseases (p=0.03). Patients diagnosed with any inflammatory eye disease (≥ 5 years) exhibited a higher propensity for CAM use (0

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.